Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 188 results
  • Sort by Sort ascending
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

Chronic Inducible Urticaria Phase 3 United States
China
Argentina
Australia
Thailand
Japan
Israel
Canada
Hong Kong
Malaysia
Turkey
Korea, Republic of
Singapore
View All

Special Drug Use Surveillance of Entresto Tablets (Hypertension)

Hypertension Japan

Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.

Lymphatic Malformations Phase 2, Phase 3 United States
Australia
France
Germany
Spain
View All

Asciminib RMP Study

Chronic Myeloid Leukemia Korea, Republic of

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

Oligometastatic Prostate Cancer (OMPC) Phase 3 Australia
Switzerland
Israel
Japan
Canada
Singapore
United States
View All

Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)

Atypical Hemolytic Uremic Syndrome Phase 3 Turkey
Japan

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

Hidradenitis Suppurativa Germany

An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)

Hyperlipoproteinemia (a) Phase 3 Germany

A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma

Follicular Lymphoma (FL) Phase 3 Spain
Slovakia
Romania
Hungary
Australia
Poland
Czech Republic
Korea, Republic of
Singapore
Taiwan
View All

A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies

Primary Immune Thrombocytopenia (ITP) Phase 2 United States
Turkey
Spain
China
Czech Republic
Argentina
Australia
France
Germany
Italy
United Kingdom
Malaysia
Poland
Korea, Republic of
View All